Paper36282125
Prognostic biomarkers correlated with immune infiltration in non-small cell lung cancer.
Xu F and 6 others. FEBS Open Bio, 2023. Cited by 13 papers, by iCite.
Cite this record
ConductScience Library. Prognostic biomarkers correlated with immune infiltration in non-small cell lung cancer. Papers, record 36282125. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36282125
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics9
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma, Non-Small-Cell Lung | Major topic |
| Lung Neoplasms | Major topic |
| Male | |
| Humans | |
| Female | |
| Prognosis | |
| Biomarkers, Tumor | |
| Signal Transduction | |
| Tumor Microenvironment |
Source PubMed
References41
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 22318521 | Cancer exome analysis reveals a T-cell-dependent mechanism of cancer immunoediting. | Nature | 2012 | https://conductscience.org/library/papers/22318521 | PubMed |
| 2 | 25594174 | Molecular and genetic properties of tumors associated with local immune cytolytic activity. | Cell | 2015 | https://conductscience.org/library/papers/25594174 | PubMed |
| 3 | 33335795 | Association of clock-like mutational signature with immune checkpoint inhibitor outcome in patients with melanoma and NSCLC. | Mol Ther Nucleic Acids | 2021 | https://conductscience.org/library/papers/33335795 | PubMed |
| 4 | 32158623 | A non-linear association between blood tumor mutation burden and prognosis in NSCLC patients receiving atezolizumab. | Oncoimmunology | 2020 | https://conductscience.org/library/papers/32158623 | PubMed |
| 5 | 29019985 | DNA sequencing at 40: past, present and future. | Nature | 2017 | https://conductscience.org/library/papers/29019985 | PubMed |
| 6 | 31199602 | Comprehensive genomic profiling of small cell lung cancer in Chinese patients and the implications for therapeutic potential. | Cancer Med | 2019 | https://conductscience.org/library/papers/31199602 | PubMed |
| 7 | 25019278 | mTOR signaling in T cell immunity and autoimmunity. | Int Rev Immunol | 2015 | https://conductscience.org/library/papers/25019278 | PubMed |
| 8 | 22588877 | The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. | Cancer Discov | 2012 | https://conductscience.org/library/papers/22588877 | PubMed |
| 9 | 31054778 | Somatic mutation of LRP1B is associated with tumor mutational burden in patients with lung cancer. | Lung Cancer | 2019 | https://conductscience.org/library/papers/31054778 | PubMed |
| 10 | 31762941 | Tumor mutational burden in lung cancer: a systematic literature review. | Oncotarget | 2019 | https://conductscience.org/library/papers/31762941 | PubMed |
| 11 | 25601901 | Notching on Cancer's Door: Notch Signaling in Brain Tumors. | Front Oncol | 2014 | https://conductscience.org/library/papers/25601901 | PubMed |
| 12 | 32995352 | Evaluating the Potential of T Cell Receptor Repertoires in Predicting the Prognosis of Resectable Non-Small Cell Lung Cancers. | Mol Ther Methods Clin Dev | 2020 | https://conductscience.org/library/papers/32995352 | PubMed |
| 13 | 28835386 | Tumor Mutational Burden as an Independent Predictor of Response to Immunotherapy in Diverse Cancers. | Mol Cancer Ther | 2017 | https://conductscience.org/library/papers/28835386 | PubMed |
| 14 | 34445735 | Failure of Immunotherapy-The Molecular and Immunological Origin of Immunotherapy Resistance in Lung Cancer. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34445735 | PubMed |
| 15 | 31164891 | Association of LRP1B Mutation With Tumor Mutation Burden and Outcomes in Melanoma and Non-small Cell Lung Cancer Patients Treated With Immune Check-Point Blockades. | Front Immunol | 2019 | https://conductscience.org/library/papers/31164891 | PubMed |
| 16 | 28522810 | Integrative analysis of genomic sequencing data reveals higher prevalence of LRP1B mutations in lung adenocarcinoma patients with COPD. | Sci Rep | 2017 | https://conductscience.org/library/papers/28522810 | PubMed |
| 17 | 29863250 | CircRNA circ_0067934 silencing inhibits the proliferation, migration and invasion of NSCLC cells and correlates with unfavorable prognosis in NSCLC. | Eur Rev Med Pharmacol Sci | 2018 | https://conductscience.org/library/papers/29863250 | PubMed |
| 18 | 34093808 | LRP1B mutation: a novel independent prognostic factor and a predictive tumor mutation burden in hepatocellular carcinoma. | J Cancer | 2021 | https://conductscience.org/library/papers/34093808 | PubMed |
| 19 | 30364244 | Notch and NF-κB: Coach and Players of Regulatory T-Cell Response in Cancer. | Front Immunol | 2018 | https://conductscience.org/library/papers/30364244 | PubMed |
| 20 | 33653800 | LRP1B mutations are associated with favorable outcomes to immune checkpoint inhibitors across multiple cancer types. | J Immunother Cancer | 2021 | https://conductscience.org/library/papers/33653800 | PubMed |
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41993133 | Shuangshen Granule Regulates Tumor Cell Exosomes Through MIF-miR-34a-KLF4 Pathway and Affects Macrophage Polarization Against Lung Cancer. | Hum Mutat | 2026 | https://conductscience.org/library/papers/41993133 | PubMed |
| 41065506 | LRP1b Loss Predicts Sensitivity to Immunotherapy in Patients with NSCLC: An Analysis of the Phase III CheckMate-026 Randomized Trial. | Clin Cancer Res | 2025 | https://conductscience.org/library/papers/41065506 | PubMed |
| 40011914 | Comprehensive genetic variant analysis reveals combination of KRAS and LRP1B as a predictive biomarker of response to immunotherapy in patients with non-small cell lung cancer. | J Exp Clin Cancer Res | 2025 | https://conductscience.org/library/papers/40011914 | PubMed |
| 39776648 | Recent advances in the role of atypical cadherin FAT1 in tumorigenesis (Review). | Oncol Lett | 2025 | https://conductscience.org/library/papers/39776648 | PubMed |
| 39281211 | Comparative analysis of the clinical effects of different thoracoscopic resection in the treatment of Stage I Non-Small Cell Lung Cancer. | Pak J Med Sci | 2024 | https://conductscience.org/library/papers/39281211 | PubMed |
| 38727881 | PCDHGA10 as a Potential Biomarker of Lung Squamous Cell Carcinoma Based on Bioinformatics and Experimental Verification. | Mol Biotechnol | 2025 | https://conductscience.org/library/papers/38727881 | PubMed |
| 38617524 | The prognostic biomarker TPGS2 is correlated with immune infiltrates in pan-cancer: a bioinformatics analysis. | Transl Cancer Res | 2024 | https://conductscience.org/library/papers/38617524 | PubMed |
| 38289488 | Vitamin D-mediated tsRNA-07804 triggers mitochondrial dysfunction and suppresses non-small cell lung cancer progression by targeting CRKL. | J Cancer Res Clin Oncol | 2024 | https://conductscience.org/library/papers/38289488 | PubMed |
| 37255669 | Patient Perspectives and Side-Effects Experience on Chemotherapy of Non-Small Cell Lung Cancer: A Qualitative Study. | Cancer Manag Res | 2023 | https://conductscience.org/library/papers/37255669 | PubMed |
| 36874015 | Targeting immune cell types of tumor microenvironment to overcome resistance to PD-1/PD-L1 blockade in lung cancer. | Front Pharmacol | 2023 | https://conductscience.org/library/papers/36874015 | PubMed |
Genes49
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36282125
GET https://conductscience.org/api/papers/v1/36282125/references?page=2